Analytical Methods Validation - ICH Q14 Overview for Regulatory Approval
Watch the Course Now
Watch the Course Now
About the Course
Analytical procedure validation remains a critical regulatory expectation across pharmaceutical and biotechnology development programs. ICH Q14 introduces a structured approach linking analytical procedure development with validation activities, supporting greater consistency in method performance, scientific justification, and regulatory documentation. Organizations submitting data to regulatory agencies must demonstrate that analytical methods are suitable for their intended use while maintaining accuracy, precision, specificity, and reliability throughout the product lifecycle.
Current regulatory scrutiny continues to focus on inadequate validation practices, poor method transfer controls, and insufficient stability-indicating capability. Failures in these areas can contribute to FDA 483 observations, delayed approvals, product recalls, and post-submission remediation work. This course addresses practical considerations for phase-appropriate validation, risk-based method development, forced degradation studies, and lifecycle management activities aligned with FDA, USP, and ICH expectations. Attention is also given to method verification, reproducibility across laboratories, and maintaining compliance after validation activities are completed.
Key Areas Covered
Quality training, expert insights, and answers that matter. Know your Expert
Ready to Strengthen Your Team? Let’s Build Your Training Plan.
Your team deserves the clarity.
Your organization deserves the confidence.
Upcoming Courses
Your TalkFDA Webinar Experience
1. Confirmation
3. Access course materials
4. Watch The Streaming and Complete your Course


